Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2025-12-24 @ 10:23 PM
NCT ID:
NCT00002235
Eligibility Criteria:
Inclusion Criteria
You may be eligible for this study if you:
* Are HIV-positive.
* Are at least 13 years old (consent of parent or guardian required if under 18).
* Have a viral load of at least 10,000 copies/ml within 30 days of study entry.
* Agree to use a barrier method of birth control, such as condoms, during the study.
Exclusion Criteria
You will not be eligible for this study if you:
* Have hepatitis.
* Have any other serious medical condition besides HIV infection.
* Are allergic to indinavir, nelfinavir, or efavirenz.
* Have ever taken NNRTIs or protease inhibitors.
* Have had chemotherapy or radiation therapy within 30 days of study entry. (Local radiation therapy is allowed.)
* Have taken certain other medications that might affect your immune system such as interleukin-2, interferon, or a vaccine within 30 days of study entry.
* Are enrolled or plan to enroll in another anti-HIV drug study during this study.
* Are pregnant or breast-feeding.
* Abuse alcohol or drugs.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
13 Years
Study:
NCT00002235
Study Brief:
Protocol Section:
NCT00002235